These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 19335418

  • 21. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
    Pacor ML, Di Lorenzo G, Martinelli N, Mansueto P, Rini GB, Corrocher R.
    Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis.
    Rubins A, Gutmane R, Valdmane N, Stevenson P, Foster C, Undre N.
    J Invest Dermatol; 2005 Jul; 125(1):68-71. PubMed ID: 15982304
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.
    Draelos Z, Nayak A, Pariser D, Shupack JL, Chon K, Abrams B, Paul CF.
    J Am Acad Dermatol; 2005 Oct; 53(4):602-9. PubMed ID: 16198779
    [Abstract] [Full Text] [Related]

  • 24. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
    [Abstract] [Full Text] [Related]

  • 25. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
    Naylor M, Elmets C, Jaracz E, Rico JM.
    J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
    [Abstract] [Full Text] [Related]

  • 26. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis.
    Patel RR, Vander Straten MR, Korman NJ.
    Arch Dermatol; 2003 Sep; 139(9):1184-6. PubMed ID: 12975161
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
    Bieber T, Vick K, Fölster-Holst R, Belloni-Fortina A, Städtler G, Worm M, Arcangeli F.
    Allergy; 2007 Feb; 62(2):184-9. PubMed ID: 17298428
    [Abstract] [Full Text] [Related]

  • 28. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A, Harper J, Rustin M, Goldschmidt WF, Palatsi R, van der Valk PG, Sharpe G, Smith CH, Dobozy A, Turjanmaa K, European Tacrolimus Ointment Study Group.
    Acta Derm Venereol; 2007 Feb; 87(1):54-61. PubMed ID: 17225017
    [Abstract] [Full Text] [Related]

  • 29. The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.
    Rustin MH.
    Br J Dermatol; 2007 Nov; 157(5):861-73. PubMed ID: 17854353
    [Abstract] [Full Text] [Related]

  • 30. Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study.
    Papp KA, Werfel T, Fölster-Holst R, Ortonne JP, Potter PC, de Prost Y, Davidson MJ, Barbier N, Goertz HP, Paul C.
    J Am Acad Dermatol; 2005 Feb; 52(2):240-6. PubMed ID: 15692468
    [Abstract] [Full Text] [Related]

  • 31. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC, Fleisher AB.
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
    Doss N, Kamoun MR, Dubertret L, Cambazard F, Remitz A, Lahfa M, de Prost Y.
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
    [Abstract] [Full Text] [Related]

  • 34. One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial.
    Mandelin J, Remitz A, Virtanen H, Reitamo S.
    Acta Derm Venereol; 2010 Mar; 90(2):170-4. PubMed ID: 20169301
    [Abstract] [Full Text] [Related]

  • 35. Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study.
    Staab D, Pariser D, Gottlieb AB, Kaufmann R, Eichenfield LF, Langley RG, Scott G, Ebelin ME, Barilla D, Schmidli H, Burtin P.
    Pediatr Dermatol; 2005 Mar; 22(5):465-71. PubMed ID: 16191004
    [Abstract] [Full Text] [Related]

  • 36. [Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and paediatric patients with atopic dermatitis].
    Undre NA.
    Actas Dermosifiliogr; 2008 Feb; 99 Suppl 2():2-7. PubMed ID: 18346423
    [Abstract] [Full Text] [Related]

  • 37. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A, Allen BR, Reitamo S.
    J Dermatolog Treat; 2003 Feb; 14(Suppl 1):5-16. PubMed ID: 14522634
    [Abstract] [Full Text] [Related]

  • 38. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients.
    Koo JY, Fleischer AB, Abramovits W, Pariser DM, McCall CO, Horn TD, Gottlieb AB, Jaracz E, Rico MJ.
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S195-205. PubMed ID: 16021175
    [Abstract] [Full Text] [Related]

  • 39. Tacrolimus ointment: utilization patterns in children under age 2 years.
    Housman TS, Norton AB, Feldman SR, Fleischer AB, Simpson EL, Hanifin JM, Antaya RJ.
    Dermatol Online J; 2004 Jul 15; 10(1):2. PubMed ID: 15347484
    [Abstract] [Full Text] [Related]

  • 40. Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature.
    Pustisek N, Lipozencić J, Ljubojević S.
    Acta Dermatovenerol Croat; 2002 Mar 15; 10(1):25-32. PubMed ID: 12137728
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.